ATE251447T1 - Pharmazeutische zubereitungen zur inhalation eines opioids - Google Patents
Pharmazeutische zubereitungen zur inhalation eines opioidsInfo
- Publication number
- ATE251447T1 ATE251447T1 AT98962686T AT98962686T ATE251447T1 AT E251447 T1 ATE251447 T1 AT E251447T1 AT 98962686 T AT98962686 T AT 98962686T AT 98962686 T AT98962686 T AT 98962686T AT E251447 T1 ATE251447 T1 AT E251447T1
- Authority
- AT
- Austria
- Prior art keywords
- opioids
- dry powder
- inhalation
- administered
- opioid
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940005483 opioid analgesics Drugs 0.000 abstract 4
- 239000000843 powder Substances 0.000 abstract 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- 206010013975 Dyspnoeas Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL1998/000713 WO2000035417A1 (en) | 1998-12-11 | 1998-12-11 | Pharmaceutical preparation for inhalation of an opioid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE251447T1 true ATE251447T1 (de) | 2003-10-15 |
Family
ID=19866466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98962686T ATE251447T1 (de) | 1998-12-11 | 1998-12-11 | Pharmazeutische zubereitungen zur inhalation eines opioids |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20010041164A1 (de) |
| EP (1) | EP1137398B1 (de) |
| JP (1) | JP2002532405A (de) |
| AT (1) | ATE251447T1 (de) |
| AU (1) | AU1786199A (de) |
| CA (1) | CA2354576C (de) |
| DE (1) | DE69818872T2 (de) |
| DK (1) | DK1137398T3 (de) |
| ES (1) | ES2207867T3 (de) |
| IL (2) | IL143576A0 (de) |
| WO (1) | WO2000035417A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| WO2002094234A1 (en) * | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of opioids through an inhalation route |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Pharmaceuticals, Inc. | Delivery of drug esters through an inhalation route |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| AU2003269989B8 (en) * | 2002-08-21 | 2009-11-12 | Norton Healthcare Ltd. | Inhalation composition |
| GB0219513D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions including coarse carrier |
| CA2556629A1 (en) * | 2003-02-28 | 2004-09-10 | Delex Therapeutics Inc. | Opioid delivery system |
| ATE510174T1 (de) | 2003-05-21 | 2011-06-15 | Alexza Pharmaceuticals Inc | Schlag gezündete unabhängige heizeinheit |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| AU2004322756B2 (en) | 2004-08-12 | 2011-04-14 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| WO2006124556A2 (en) * | 2005-05-13 | 2006-11-23 | Glaxo Group Limited | Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| EP2389159A1 (de) * | 2009-01-22 | 2011-11-30 | Noramco, Inc. | Verfahren zur herstellung von opioid-partikeln und so hergestellte zusammensetzungen |
| US12214118B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| GB9103302D0 (en) * | 1991-02-16 | 1991-04-03 | Smithkline Beecham Plc | Pharmaceutical formulations |
| US6017963A (en) * | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
| GB9606188D0 (en) * | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
-
1998
- 1998-12-11 ES ES98962686T patent/ES2207867T3/es not_active Expired - Lifetime
- 1998-12-11 CA CA002354576A patent/CA2354576C/en not_active Expired - Fee Related
- 1998-12-11 DE DE69818872T patent/DE69818872T2/de not_active Expired - Fee Related
- 1998-12-11 IL IL14357698A patent/IL143576A0/xx not_active IP Right Cessation
- 1998-12-11 DK DK98962686T patent/DK1137398T3/da active
- 1998-12-11 JP JP2000587738A patent/JP2002532405A/ja active Pending
- 1998-12-11 WO PCT/NL1998/000713 patent/WO2000035417A1/en not_active Ceased
- 1998-12-11 AU AU17861/99A patent/AU1786199A/en not_active Withdrawn
- 1998-12-11 EP EP98962686A patent/EP1137398B1/de not_active Expired - Lifetime
- 1998-12-11 AT AT98962686T patent/ATE251447T1/de not_active IP Right Cessation
-
2001
- 2001-06-05 IL IL143576A patent/IL143576A/en unknown
- 2001-06-11 US US09/877,078 patent/US20010041164A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20010041164A1 (en) | 2001-11-15 |
| WO2000035417A1 (en) | 2000-06-22 |
| DK1137398T3 (da) | 2004-02-02 |
| DE69818872D1 (de) | 2003-11-13 |
| IL143576A (en) | 2006-10-31 |
| CA2354576A1 (en) | 2000-06-22 |
| ES2207867T3 (es) | 2004-06-01 |
| DE69818872T2 (de) | 2004-05-19 |
| EP1137398B1 (de) | 2003-10-08 |
| EP1137398A1 (de) | 2001-10-04 |
| JP2002532405A (ja) | 2002-10-02 |
| AU1786199A (en) | 2000-07-03 |
| IL143576A0 (en) | 2002-04-21 |
| CA2354576C (en) | 2008-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE251447T1 (de) | Pharmazeutische zubereitungen zur inhalation eines opioids | |
| CA2146954A1 (en) | Breath activated nicotine inhalers | |
| AU2017228051B2 (en) | Nicotine formulation and aerosols | |
| EE03221B1 (et) | Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks | |
| DK1019021T3 (da) | Stabiliserede præparater til anvendelse i inhalatorer med afmålt dosis | |
| EA200100338A1 (ru) | Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента | |
| DE69921785D1 (de) | Nikotininhalator | |
| TNSN04149A1 (en) | Pressurised metered dose inhalers containing solutions of beta-2 agonists | |
| Newman et al. | The nasal distribution of metered does inhalers | |
| JP2001527442A (ja) | ハロセラピーの投与方法 | |
| BR0011343A (pt) | Dispositivo de distribuição de medicamento,e,métodos de administrar um medicamento por inalação,e de,tratamento de um paciente com distúrbio respiratório | |
| TW200607538A (en) | Medicament inhaler device | |
| US11006661B2 (en) | Cigarette-like device for administration of substances | |
| FI962665A0 (fi) | Menetelmä ja sovitelma intuboidun potilaan hengityMenetelmä ja sovitelma intuboidun potilaan hengityskaasun käsittelemiseksi skaasun käsittelemiseksi | |
| Calvert et al. | Enhanced delivery of nebulised salbutamol during non‐invasive ventilation | |
| NO20021681L (no) | Anordning for avlevering av medikament, med fuktighetsbestandig belegg | |
| Hofmann et al. | Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis | |
| Pedersen et al. | Comparative efficacy of different methods of nebulising terbutaline | |
| Silkstone et al. | Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser | |
| WO1997047344A1 (en) | Method and device for facilitating the use of medical apparatus by patients | |
| RU2012363C1 (ru) | Устройство в.а.старцева для насыщения воздуха лекарственными веществами | |
| KIM et al. | The effect of patient education on correct use of metered dose inhalers in patients with asthma | |
| EP1110547A3 (de) | Helium und Neon als Hilfsstoffe zur Wirkstoffverabreichung mittels Inhalator | |
| CN101146563B (zh) | 气雾剂形式的药品的给药设备 | |
| Steed et al. | The oropharyngeal and lung deposition patterns of a fusafungine MDI spray delivered by HFA 134a propellant or by CFC 12 propellant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1137398 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |